In recent years, NAF-1 has gained increasing interest, and it was found that NAF-1 expression is increased in a variety of tumors, including gastric cancer (19), prostate cancer (20), cervical cancer (21), liver cancer (22), and laryngeal cancer. This evidence concerns the gene NAF1 and prostate cancer.